Cosmo Feilding Mellen
Director Ejecutivo en Beckley Canopy Therapeutics Ltd. .
Cargos activos de Cosmo Feilding Mellen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beckley Canopy Therapeutics Ltd.
 Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
Beckley Psytech Ltd.
 Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Director/Miembro de la Junta | 01/01/1998 | - |
| Director Ejecutivo | 01/01/1998 | - | |
| Fundador | 01/01/1998 | - |
Historial de carrera de Cosmo Feilding Mellen
Estadísticas
Internacional
| Reino Unido | 3 |
Operativa
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Sectorial
| Commercial Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Beckley Canopy Therapeutics Ltd.
Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Beckley Psytech Ltd.
Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Health Technology |
